China (Mainland)
Assessedsupplier
Posaconazole intermediate CAS NO.183871-36-5
- Min.Order: 10 Gram
- Payment Terms: L/C,T/T
- Product Details
Keywords
- [(2S,3S)-2-(benzyloxy)pentan-3-yl]hydrazine
- Chiral compound
- commercial production from grams to tons, with technical documents support and audit/inspection support
Quick Details
- ProName: Posaconazole intermediate
- CasNo: 183871-36-5
- Molecular Formula: C30H34N2O9
- Appearance: solid
- Application: Posaconazole intermediate
- DeliveryTime: within 4 weeks
- PackAge: standard package
- Port: TBC
- ProductionCapacity: commercial production Metric Ton/Day
- Purity: 99%
- Storage: Sealed in dry,Room Temperature
- Transportation: Non-hazardous
- LimitNum: 10 Gram
- Moisture Content: ≤0.5%
- Impurity: ≤1.0%
- any individual impurity: ≤ 0.10%
Superiority
Multi-target purpose intermediate with wide usage
Commercial production from grams to tons, with technical documents package support, and audit and inspection support.
With high purity and optimized and stable process.
Self Innovation
Details
MW: 566.61
Self Innovation
SENOVA PHARMA is committed to the development and production of API’s, advanced intermediates and biochemical products.
We insist on product development and production technology platform combining chemical synthesis (drug synthesis) technology, enzyme synthesis (biocatalytic and biotransformation) technology and microbial fermentation (biosynthesis) technology.
Our own production base and our cooperative plants in China produce products according to cGMP application, providing customers with stable and reliable whole-chain solutions， esp in anti-tumor and anti-cancer fields.